Safety and Efficacy of CCT301 CAR-T in Adult Subjects With Recurrent or Refractory Stage IV Renal Cell Carcinoma
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2
Clinical Trials Related to Renal Cell Carcinoma
Related studies linked through entity extraction aliases.
Functional Microscale Organotypic Assays to Predict Patient Response to Anti-Angiogenesis Therapies
- Status
- TERMINATED
- Phase
- PHASE2
Registry Platform Urologic Cancer
- Status
- RECRUITING
- Phase
- N/A
A Study of LY3381916 Alone or in Combination With LY3300054 in Participants With Solid Tumors
- Status
- TERMINATED
- Phase
- PHASE1
Neoadjuvant AXITINIB and AVELUMAB for Patients With Localized Clear-cell RCC
- Status
- UNKNOWN
- Phase
- PHASE2
Using Virtual Reality (VR) Models for Preoperative Planning
- Status
- COMPLETED
- Phase
- NA
A Study of CDX-1140 (CD40) as Monotherapy or in Combination in Patients With Advanced Malignancies
- Status
- COMPLETED
- Phase
- PHASE1
Lenvatinib and Everolimus in Renal Cell Carcinoma (RCC)
- Status
- COMPLETED
- Phase
- PHASE1
Study of Propranolol Plus Sunitinib in First-line Treatment of Metastatic Renal Cell Carcinoma
- Status
- WITHDRAWN
- Phase
- PHASE2
FATE-NK100 as Monotherapy and in Combination With Monoclonal Antibody in Subjects With Advanced Solid Tumors
- Status
- COMPLETED
- Phase
- PHASE1
Nivolumab in Combination With Ipilimumab in Patients With Metastatic Renal Cell Carcinoma
- Status
- COMPLETED
- Phase
- PHASE2
A Study of Recombinant Vaccinia Virus in Combination With Cemiplimab for Renal Cell Carcinoma
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1/PHASE2
Analysis of Primary and Metastatic Tumors in Patients With Renal Cell Carcinoma and Urothelial Carcinoma
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- N/A
Renal Adjuvant MultiPle Arm Randomised Trial
- Status
- RECRUITING
- Phase
- PHASE3
RFR Change of Precise Segmental Versus Complete Renal Arterial Clamping During LPN for Clinical T1 RCC
- Status
- UNKNOWN
- Phase
- NA
QUILT-3.055: A Study of Combination Immunotherapies in Patients Who Have Previously Received Treatment With Immune Checkpoint Inhibitors
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
TRACERx Renal CAPTURE Sub-study
- Status
- UNKNOWN
- Phase
- N/A
Phase 1 Study of CK-301 (Cosibelimab) as a Single Agent in Subjects With Advanced Cancers
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1
A Trial of Niraparib in BAP1 and Other DNA Damage Response (DDR) Deficient Neoplasms (UF-STO-ETI-001)
- Status
- COMPLETED
- Phase
- PHASE2
Cabometyx and Avelumab in Patients With Metastatic Renal Cell Carcinoma (mRCC)
- Status
- COMPLETED
- Phase
- PHASE1